Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0V9MG
|
|||
| Former ID |
DIB014895
|
|||
| Drug Name |
KY-382
|
|||
| Indication | Arteriosclerosis [ICD-11: BD40; ICD-10: I70] | Investigative | [1] | |
| Company |
Kyoto Pharmaceutical Industries Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H32N4O4S
|
|||
| Canonical SMILES |
CCOCCN1CCC2=C(C(=C(C(=C21)NC(=O)C(C)(C)C)C)NS(=O)(=O)N)C
|
|||
| InChI |
1S/C19H32N4O4S/c1-7-27-11-10-23-9-8-14-12(2)15(22-28(20,25)26)13(3)16(17(14)23)21-18(24)19(4,5)6/h22H,7-11H2,1-6H3,(H,21,24)(H2,20,25,26)
|
|||
| InChIKey |
PXCNVWWWTVXCME-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Liver carboxylesterase (CES1) | Target Info | Modulator | [1] |
| KEGG Pathway | Drug metabolism - other enzymes | |||
| Metabolic pathways | ||||
| Pathway Interaction Database | E2F transcription factor network | |||
| WikiPathways | NRF2 pathway | |||
| Nuclear Receptors Meta-Pathway | ||||
| Heroin metabolism | ||||
| Irinotecan Pathway | ||||
| Fluoropyrimidine Activity | ||||
| Phase I biotransformations, non P450 | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2592). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.